Cannabidiol for Reduction of Brain Neuroinflammation
Phase 2
80
about 4.9 years
18–75
1 site in MA
What this study is about
Researchers are testing whether cannabidiol (CBD), a treatment, can reduce brain inflammation in adults with chronic pain and/or depression. The trial will last 1806 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take CBD
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
cannabinoid
Secondary: Change in Clinical Pain Ratings, Change in Depressive Symptoms, Change in Pain Bothersomeness, Correlation Between Reductions in Limbic [11C]PBR28 PET Signal and Reductions in Depressive Symptoms, Correlation Between Reductions in Thalamic [11C]PBR28 PET Signal and Reductions in Clinical Pain Ratings, Patient Global Impression of Change
Psychiatry / Mental Health